Immunomedics Announces Results From Two Clinical Trials at Hematology Conference

Immunomedics, Inc.

, today announced that two studies conducted by outside investigators that involved the Company's antibody drug candidates were presented at the 53^rd Annual Meeting of the American Society of Hematology.